Follow us on
Search
Close this search box.

Dr. ZEYNEP GURAL

Dr. Zeynep Gural, Radiation Oncologist

Snapshot Highlights

  • Over 10 years of experience in Radiation Oncology
  • Specialized training and observer experience in Amsterdam, Netherlands
  • Published author in peer-reviewed journals including Breast, Cancer Chemother Pharmacol, and Medicine
  • Active member of prestigious organizations like ESTRO and the Neuro-Oncology Association
  • Expertise in advanced oncology treatments and patient care

Dr. ZEYNEP GURAL

Education

  • Istanbul University Istanbul Faculty of Medicine, Radiation Oncology (2009)
  • Istanbul University Cerrahpasa Medical Faculty (2003)

Professional Experience

  • Acıbadem Health Group (2014 – Present)
  • Lecturer at Bezmialem Vakif University (2012 – 2014)
  • Specialist Doctor at Balikesir State Hospital (2010 – 2012)
  • Clinical Observer at AMC, Amsterdam, Netherlands (2009)

Professional Memberships

  • Neuro-Oncology Association
  • Turkish Radiation Oncology Association
  • European Society for Therapeutic Radiology and Oncology (ESTRO)
  • Lung Cancer Association

Key Publications

  • Bone health in breast cancer patients: A comprehensive statement by CECOG/SAKK Intergroup. (Breast, 2014)
  • Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study. (Cancer Chemother Pharmacol, 2014)
  • Does early PET/CT assessment of response to chemotherapy predict survival in patients with advanced stage non-small-cell lung cancer? (Medicine (Baltimore), 2014)
  • Comparison of two different adjuvant treatment modalities for pN3 gastric cancer patients after D2 lymph node dissection: can we avoid radiotherapy in a subgroup of patients? (Med Oncol, 2013)
  • Skin Recurrence of a Phyllodes Tumor and Impact of Radiotherapy: A Case Report and Review of the Literature. (Journal of Cancer Research Updates, 2013)
  • Can diffusion-weighted MRI determine complete responders after neoadjuvant chemoradiation for locally advanced rectal cancer? (Diagn Interv Radiol, 2012)
  • Primary Breast Lymphoma; Recurrent Disease. (Turkish Journal of Oncology, 2012)